TP53 and neoplasm: There were no significant differences in age at diagnosis, age group distribution, tumor size, TNM stage, ER, PR, hormone receptor status, immunophenotype, p53, type of surgery, chemotherapy, radiotherapy and endocrine therapy (Table 1).